NCT04764461

Brief Summary

A prospective randomised control trial to evaluate the effectiveness of customised growth charts for detection of small for gestational age fetus in low risk women, in comparison to conventional standard of care.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 14, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

February 14, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 21, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2022

Completed
Last Updated

February 21, 2021

Status Verified

February 1, 2021

Enrollment Period

1.4 years

First QC Date

February 14, 2021

Last Update Submit

February 17, 2021

Conditions

Keywords

Small for gestational ageSGAGROW ChartLow risk

Outcome Measures

Primary Outcomes (1)

  • Change in detection rate of SGA in low risk women using GROW charts

    detection rate of Small for gestational age in control and intervention group

    1.5 years

Secondary Outcomes (6)

  • Change in perinatal outcomes between control and Intervention group in low risk women.

    1.5 years

  • Rate of Apgar score at the time of birth

    1.5 years

  • Rate of Type of labor in control and intervention group

    1.5 years

  • Rate of mode of delivery in the control and Intervention group

    1.5 years

  • Rate of newborns requiring hospital admissions for postnatal care

    1.5 years

  • +1 more secondary outcomes

Study Arms (2)

Control Group

NO INTERVENTION

The control group will continue with the standard practice of antenatal care using Mc Donald's rule for fundal heights measurements.

Intervention Group

EXPERIMENTAL

Intervention group will follow the same antenatal visit plan as the control group with the use of customised GROW Charts for fundal height measurements.

Other: Use of customised GROW Charts

Interventions

Intervention group will follow the same antenatal visit plan and two ultrasounds will be offered (NT 11-13+6 weeks \& anomaly scan 19-22 weeks of gestation) in routine. A third trimester scan will not be offered in routine to Intervention group. Serial SFH measurements will be plotted against estimated date of delivery at each review from 26 weeks of gestation on the customized GROW chart already attached in the maternity notes. On each visit patient will be examined after emptying bladder in a semi-recumbent position, using non-elastic tape with cm side hidden; measurement will be taken from the fundus to upper margin of pubic symphysis. Abnormal SFH measurements, when plotted below the 10th or does not follow its trajectory on customized growth charts will be referred for growth scan suspecting SGA. SFH plotted above 90th centile will also be referred for growth scan, as a part of antenatal care.

Intervention Group

Eligibility Criteria

Age19 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • low risk woman with singleton pregnancy.

You may not qualify if:

  • Pregnant woman with chronic hypertension, Diabetes Mellitus, Autoimmune disorders
  • Fetus with chromosomal
  • Fetus with structural defects
  • Multiple gestation
  • Pregnancy with fibroids uterus
  • BMI \>35.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fatima Memorial College of Medicine and Dentistry

Lahore, Punjab Province, 54000, Pakistan

RECRUITING

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 14, 2021

First Posted

February 21, 2021

Study Start

February 14, 2021

Primary Completion

July 15, 2022

Study Completion

July 15, 2022

Last Updated

February 21, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations